Prof.Dr.med. ID: 6488383
Katja Weisel
Publications
The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas
Adam, P., Baumann, R., Schmidt, J., Bettio, S., Weisel, K., Bonzheim, I., Fend, F. & Quintanilla-Martínez, L., 09.2013, In: HUM PATHOL. 44, 9, p. 1817-26 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Cirrincione, A. M., Poos, A. M., Ziccheddu, B., Kaddoura, M., Baertsch, M-A., Maclachlan, K. H., Chojnacka, M., Diamond, B. T., John, L., Reichert, P., Huhn, S., Blaney, P., Gagler, D. C., Rippe, K., Zhang, Y., Dogan, A., Lesokhin, A. M., Davies, F. E., Goldschmidt, H., Fenk, R., Weisel, K. C., Mai, E. K., Korde, N., Morgan, G. J., Usmani, S. Z., Landgren, O., Raab, M. S., Weinhold, N. & Maura, F., 15.08.2024, In: BLOOD. 144, 7, p. 771-783 13 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
Awwad, M. H. S., Kriegsmann, K., Plaumann, J., Benn, M., Hillengass, J., Raab, M. S., Bertsch, U., Munder, M., Weisel, K., Salwender, H. J., Hänel, M., Fenk, R., Dürig, J., Müller-Tidow, C., Goldschmidt, H. & Hundemer, M., 2018, In: ONCOIMMUNOLOGY. 7, 10, p. e1486356Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Moreau, P., Kumar, S. K., San Miguel, J., Davies, F., Zamagni, E., Bahlis, N., Ludwig, H., Mikhael, J., Terpos, E., Schjesvold, F., Martin, T., Yong, K., Durie, B. G. M., Facon, T., Jurczyszyn, A., Sidana, S., Raje, N., van de Donk, N., Lonial, S., Cavo, M., Kristinsson, S. Y., Lentzsch, S., Hajek, R., Anderson, K. C., João, C., Einsele, H., Sonneveld, P., Engelhardt, M., Fonseca, R., Vangsted, A., Weisel, K., Baz, R., Hungria, V., Berdeja, J. G., Leal da Costa, F., Maiolino, A., Waage, A., Vesole, D. H., Ocio, E. M., Quach, H., Driessen, C., Bladé, J., Leleu, X., Riva, E., Bergsagel, P. L., Hou, J., Chng, W. J., Mellqvist, U-H., Dytfeld, D., Harousseau, J-L., Goldschmidt, H., Laubach, J., Munshi, N. C., Gay, F., Beksac, M., Costa, L. J., Kaiser, M., Hari, P., Boccadoro, M., Usmani, S. Z., Zweegman, S., Holstein, S., Harrison, S., Nahi, H., Cook, G., Mateos, M-V., Rajkumar, S. V., Dimopoulos, M. A. & Richardson, P. G., 03.2021, In: LANCET ONCOL. 22, 3, p. e105-e118Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry
Lee, H. C., Ramasamy, K., Weisel, K., Abonour, R., Hardin, J. W., Rifkin, R. M., Ailawadhi, S., Terebelo, H. R., Durie, B. G. M., Tang, D., Joshi, P., Liu, L., Jou, Y-M., Che, M., Hernandez, G., Narang, M., Toomey, K., Gasparetto, C., Wagner, L. I. & Jagannath, S., 02.2023, In: CL LYMPH MYELOM LEUK. 23, 2, p. 112-122 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
Auel, B., Goldschmidt, H., Geer, T., Moehler, T. M., Platzbecker, U., Naumann, R., Blau, I., Hänel, M., Knauf, W., Nückel, H., Salwender, H-J., Scheid, C., Weisel, K., Gorschlüter, M., Glasmacher, A., Schmidt-Wolf, I. G. H. & German Refractory Myeloma Study Group, 06.2012, In: INDIAN J HEMATOL BLO. 28, 2, p. 67-76 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience
Ghandili, S., Alihodzic, D., Wiessner, C., Bokemeyer, C., Weisel, K. & Leypoldt, L. B., 01.2023, In: ANN HEMATOL. 102, 1, p. 117-124 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
What do hematologists and oncologists consider necessary for their career?: Results of an online survey in Germany, Austria and Switzerland
Giesler, M., Busson-Spielberger, M., Miemietz, B., de Wit, M., Weisel, K. & Lüftner, D., 07.2023, In: J CANCER RES CLIN. 149, 8, p. 5331-5344 14 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results
Horger, M., Weisel, K., Horger, W., Mroue, A., Fenchel, M. & Lichy, M., 06.2011, In: AM J ROENTGENOL. 196, 6, p. W790-5Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells
Weisel, K. C., Kopp, H-G., Moore, M. A. S., Studer, L. & Barberi, T., 05.2010, In: STEM CELLS DEV. 19, 5, p. 745-51 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review